dimarts, 19 d’agost del 2014

Masimo receives warning letter from FDA over its Pronto 7 pulse oximeters | Regulatory news for the week of August 18, 2014




Here's a look at some of the top regulatory stories for medical device companies this week: Masimo reveals FDA warning letter over Pronto 7 monitor; FDA issues new draft guidance on Class III de novos, UDI for small entities; Medicare finalizes coverage for MitraClip






Masimo reveals FDA warning letter over Pronto 7 monitor


August 15, 2014 by Brad Perriello




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1oNAOeI

Cap comentari:

Publica un comentari a l'entrada